Some individuals may experience minor side effects, such as mild redness at the injection site, but these are generally temporary
BPC-157 Arginate (Pentadeca Arginate) has not been approved by the FDA for the treatment, prevention, or cure of any disease
Balances concentration with syringe precision | | 50mg | 5mL | 10mg/mL | 0.5mL (50 units) | 1.0mL (100 units) | Lower concentration improves measurement accuracy but uses solution faster | | 100mg | 2mL | 50mg/mL | 0.1mL (10 units) | 0.2mL (20 units) | Higher vial amount extends total doses but requires same precision as 50mg/1mL | | 100mg | 4mL | 25mg/mL | 0.2mL (20 units) | 0.4mL (40 units) | Optimal for multi-week protocols
Independently tested for endotixins, sterility and benzyl alcohol level.
With the right preparation and a little patience, you can handle the reconstitution process at home
The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolts test and chronic unpredictable stress in rats
